RAHMAN SHAH,MD,FACC,FSCAI

Associate Professor
Medicine-Cardiology
UTHSC, Memphis, TN

Director, Cardiac Catheterization Lab
Veterans Affairs Medical Center (Memphis)

Office: 1030 JEFFERSON AVENUE MEMPHIS TN 38104
Tel: (901) 523-8990
rshah7@uthsc.edu

Education

  • Other, VCU, Richmond, VA, Interventional Cardiology
  • Other, University of Louisville , KY
  • Other, Brigham &Women /Harvard, Boston MA, Research/Imaging fellowship
  • Other, Yale University New Haven CT, Research/Nuclear fellowship
  • Other, Duke University Durham NC, Internal Medicine Residency
  • M.D., Aga Khan University Pakistan, Medicine

Clinical Care Specialty/Interest

Interventional Cardiology

Publications

  1. Shah R, McMurray JM, Kober L, Pfeffer MA. Cardiac Structure and Function in Diabetics with Acute Myocardial infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both: the VALIANT Echo Study. JACC. 2007. 49(9); S1: A42-A98..
  2. Shah R, Jasper J, Goswami R, Rogers KC. Relative Efficacy and safety of P2Y12 inhibitors in NSTEMI: A Comprehensive Network Meta-Analysis of Randomized Trials. Catheter Cardiovasc Interv.2016;87 Suppl 2:S16-S18. doi: 10.1002/ccd.26513..
  3. Shah R, Keough LA, Belalcazar-Portacio A, Ramanathan KB.. Ticagrelor as an alternative in clopidogrel-associated neutropenia.. Platelets. 2014 Jan 16;.
  4. Shah R, Khan MR, Matin K.. Preventive angioplasty in myocardial infarction.. New England J Med 2014;370(3):281.
  5. Shah R, Duncan S. Ramanathan KB.. Cocaine induced ST elevation MI.. Acute Med. 2014;13(2):72-3.
  6. Shah R, Matin K.. New oral anticoagulants in patients with atrial fibrillation.. Lancet. 2014;384:23-24.
  7. Shah R. Myocardial ischemic events in 'real world' patients treated with dabigatran.. Am J Med; 2014 Oct;127(10):e19.
  8. Shah R, Roberts KM, Ramanathan KB.. Influence of Chronic Kidney Disease on Warfarin Therapy for Atrial Fibrillation. JAMA. 2014;311(24):2542..
  9. Shah R, Mooney MA.. Complete versus culprit-only revascularisation for ST-segment elevationmyocardial infarction. Heart 2016.
  10. Shah R, Burg MM, Vashist A, Collins D, Liu J, Jadbabaie F, Graeber B, Earley C, Lampert R, Soufer R.. C-reactive protein and vulnerability to mental stress-induced myocardial ischemia.. Molecular Medicine (2006)12;10..
  11. Shah R, Wang Y, Foody JM.. Gender and racial difference in the outcomes and guideline-based management of troponin only positive acute myocardial infarction in older persons. Am J Geriatr Cardiology (2006)15;5..
  12. Shah R, Wang Y, Foody JM.. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.. American Journal of Cardiology 2008 Jan 15;101(2):217-222..
  13. Shah R.. Pioglitazone vs glimepiride in the PERISCOPE trial. JAMA. 2008 Aug 20;300(7):787-8..
  14. Shah R.. Protease-activated receptors in cardiovascular health and diseases.. Am Heart J. 2009 Feb;157(2):253-62.
  15. Shah R, Rashid A, Deam AG.. Dangerous cold Beverages.. Am J Med; 2014. 127(7):e3-4.
  16. Shah, R.. Renal denervation for resistant hypertension-the Symplicity HTN-1 study.. Lancet.2014; 383(9932):1885.
  17. Shah R, Khan, MR.. Comparative safety of vascular closure devices.. Annals of internal Medicine. 2014:160(6):438..
  18. Shah R. Linagliptin for elderly patients with type 2 diabetes.. Lancet. 2014 Jan 25;383(9914):306-7.
  19. Foody JM, Shah R, Galusha D, Greenspan M, Masoudi FA, Havranek EP, Krumholz HM.. Statins and mortality among elderly patients hospitalized with heart failure.. Circulation. 2006; 113:1086 – 1092..
  20. Shah R, Wang Y, Masoudi FA, Havranek EP, Foody JM.. Prognosis of troponin only positive myocardial infarction in elderly. Crit Pathways in Cardiol 2006;5: 160-166.
  21. Shah,R. Endothelins in Health and Diseases. Eur J Intern Med. 2007 Jul;18(4):272-82.
  22. Shah R, Foody J. Caring for the advanced elderly with acute coronary syndromes. Cardiology Reports. 2006; 8(4): 289-95.
  23. Shah R.. Invasive Strategy for Acute Coronary Syndrome in The Very Elderly. Lancet 2016.
  24. Shah R.. Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome. J Am Coll Cardiol Intv. 2016;9(14):1517-1518.
  25. Morsy M, Slomka T, Shah R. High-volume Forced Diuresis with Matched Hydration Using the RenalGuard System to Prevent Contrast-Induced Nephropathy: A Meta-analysis of Randomized Trials. Cath and Card Interventions 89(Supplement S2):S68 · May 2017..
  26. Shah R/. Short-term versus Long-term Triple Antithrombotic Therapy for Patients with Drug-eluting Coronary Stents who Require Oral Anticoagulation: Catheter Cardiovasc Interv. 2017;89(Supplement S2):S113..
  27. Shah R, Gardner J, Goswami R.. Meta-analysis of randomized trials comparing multivessel versus Infarct Artery-Only revascularization for patients with ST-Segment elevation myocardial Infarction and multivessel Coronary Artery Disease. J Am Coll Cardio (Supplement ). 2016;67(13_S):97-97..
  28. Shah R, Shell A, Chaudhry A, Hesterberg K.. Bivalirudin with Post-Procedure Infusion Versus Heparin Without Glycoprotein IIb/IIIa Inhibitors for the Prevention of Stent Thrombosis; A Meta-analysis. J Am Coll Cardiol. 2018;71(11S) A1401;..
  29. Shah R, Butt A, Nayyar N, Rashid A.. Impact of Complete Revascularization on Hard Outcomes in Patients with ST-Elevation Myocardial Infarction: An Updated Comprehensive Meta-Analysis. J Am Coll Cardiol. 2018;71(11S) A1107..
  30. Shah R.. Very Late and Very Very Late Device Thrombosis with Bioresorbable Vascular Scaffolds: A Comprehensive Meta-analysis of Randomized Controlled Trials.JACC 2017; 70(18):B327..
  31. Shah R, Heckle M.. Updated Comprehensive Meta-analysis Comparing Drug-Eluting Stents With Bare Metal Stents in Saphenous Vein Graft Interventions. J Am Coll Cardiol. 2017; 69(11):103..
  32. Shah R, Gardner J, Hwang I, Goswami R,. Percutaneous coronary intervention from femora approach by radial experts in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials. J Am Coll Cardiol (Supplement ). 2016;67(13_S):59-59..
  33. Shah R, Askari R, Mizeracki A.. Bivalirudin versus Heparin Use in Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Controlled Trials. J Am Coll Cardiol(Supplement ). 2015;65(10_S)...
  34. Chung LH, Shah R, Hou LJ, Yeh HI.. Role Of Regional Geometric Dyssynchrony By Real-time Three-dimensional Echocardiography As A Determinant Of Functional Mitral Regurgitation In Patients With Acute Myocardial Infarction. Circulation. 2007;116:II-764..
  35. Hesterberg K, Latham SB, Shah R. Aspirin alone versus dual antiplatelet therapy after coronary artery bypass surgery: A Comprehensive Pairwise and Network Meta-Analysis of Randomized Controlled Trials. Catheter Cardiovasc Interv. 2018;89(S2)..
  36. Shah R.. Instantaneous Wave-free Ratio versus Fractional Flow Reserve Guided Coronary Revascularization: A Comprehensive Meta-analysis of Randomized Controlled trials. JACC 2017; 70(18):B137...
  37. Khan SA, Heckle M, Rashid A, Shah R.. Drug Eluting Stents are Associated with Improved Survival in Patients with Unprotected Left Main Coronary Artery Disease: An Updated Comprehensive Network Meta-analysis of Randomized Trials. Catheter Cardiovasc Interv. 2017;89(Supplement S2):S113..
  38. Khan SA, Heckle M, Shah,R. Safety of Various Anticoagulation Strategies for Primary Percutaneous Coronary Intervention: An Updated Comprehensive Network Meta-analysis of Randomized Controlled Trials. Catheter Cardiovasc Interv. 2017;89(Supplement S2):S113..
  39. Shah R.. Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials. J Am Coll Cardiol (Supplement ). 2016 ;68(18S):B41-B42..
  40. Shah R, Mizeracki A. Effect of Stem Cell Therapy on All-Cause Mortality in Patient with Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Journal of Cardiac Failure(S upplement ). 2016; 22(8); S67..
  41. Shah R, Rashid R, Jasper J, Mattox A,. Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Net adverse clinical events: An Updated Meta-Analysis of Randomized Controlled Trials. Catheter Cardiovasc Interv.2016;87 Suppl 2: S117-S118. doi: 10.1002/ccd.26513..
  42. Nayyar M, Bondy N, Reddy N, Shah R.. Nayyar M, Bondy N, Reddy N, Shah R. Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke. An Updated comprehensive meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2018;71(11S) A559..
  43. Shah R, Mizeracki A.. An Update Meta-Analysis of Randomized Trials Comparing Short-Term and Long-Term Dual Antiplatelet Therapy Following Drug-Eluting Stents(Supplement ). J Am Coll Cardiol. 2015, Vol. 67, No. 13_S..
  44. Khan S, Harper Y, Slomka T, Shah R.. An updated comprehensive meta-analysis of randomized controlled trials comparing radial versus femoral access for percutaneous interventions in patient with acute coronary syndrome. J Am Coll Cardiol. 2016;67(13_S):89-89...
  45. Shah R, Hesterberg K.. Antiplatelet Therapy After Coronary Artery Bypass Grafting. JAMA. 2018 Sep 11;320(10):1035. doi: 10.1001/jama.2018.10442..
  46. Shah R, Nayyar M, Bondy B, Shell A, Rogers K,. Effect of Preprocedural Heparin Administration on Bivalirudin-Based Anticoagulation Strategy During Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. J Am Coll Cardiol. 2018;71(11S) A1402..
  47. Morsy M, Shah R.. Relative Efficacy of Various Generation Drug-Eluting Stents and Coronary Artery Bypass Grafting for Left Main Disease. Catheter Cardiovasc Inter . 017;89(S2):S113..
  48. Shah R, Khan SA, Morsy.. Effects of Various Combinations of Access Site and Anticoagulation Regime during Primary Percutaneous Coronary Intervention on Survival: Catheter Cardiovasc Interv. 2017;89(Supplement S2):S113..
  49. Shah R, Heckle M, M, Slomak T, Morsy M.. Prophylactic Defibrillator Implantation in Patients with Non-ischemic cardiomyopathy: An Updated Comprehensive Meta-analysis of Randomized controlled trials. J Am Coll Cardiol. 2017; 69(11):321..
  50. Morsy M, Shahreya M, Morsy M, Heckle, Shah R.. Shorter- versus Longer-Duration Triple Antithrombotic Therapy for Patients with Coronary Stents who Require Oral Anticoagulation: An Updated Comprehensive Meta-analysis. J Am Coll Cardiol. (Supplement) 2017; 69(11):204 ·..
  51. Shahreya M, Morsy M, Rogers K, Shah R.. An Updated Comprehensive Meta-analysis of Randomized Trials Evaluating the Efficacy of Stem Cell Therapy for Refractory Angina. J Am Coll Cardiol (Supplement). 2017; 69(11):15..
  52. Shah R, Hwang I, Manu N,.. Association Between Operator Experience with Access Type in Percutaneous Coronary Intervention and Outcomes in Patients with Acute Coronary Syndrome: J Am Coll Cardio (Supplement )l. 2016;68(18S):B40-B41..
  53. Shah R, Rashid R, Jasper J.. Contrast Use in Relation to the Arterial Access Site Used for Percutaneous Coronary Intervention: An Updated Comprehensive Meta-analysis of Randomized Trails. Catheter Cardiovasc Interv.2016;87 Suppl 2: S43-44. doi: 10.1002/ccd.26513..
  54. Shah, R. Shelton MR.. Lesson of the month 1: broken heart in the intensive care unit. Clinical Medicine. 2014; 14 (4)..
  55. Shah, R, Khan, SA, Khan, B, Latham, SB. Short-term versus long-term triple antithrombotic therapy for patients with coronary stents and requiring oral anticoagulation: a meta-analysis of randomized clinical trials. Coron Artery Dis, 2018.
  56. Shah, R, Latham, SB. Letter by Shah and Latham Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With the Guidelines-Heart Failure". Circulation, 138 (20), 2303-2304, 2018.
  57. Shah, R, Rao, SV, Latham, SB, Kandzari, DE. Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis. JAMA Cardiol, 3 (11), 1050-1059, 2018.
  58. Shah, R, Wilson, SM, Dennis, MM, Khan, B, Latham, SB. A Brief Meta-analysis of Oxygen Therapy for Normoxemic Patients with Acute Coronary Syndrome. Am J Med Sci, 2018.
  59. Shah, R, Jovin, IS, Chaudhry, A, Haji, SA, Askari, R, Dennis, MM, Berzingi, C, Rao, SV. Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary intervention. Catheter Cardiovasc Interv, 2018.
  60. Shah, R, Jovin, IS, Latham, SB, Hesterberg, K, Heckle, MR, Rashid, A, Vetrovec, GW. A comprehensive meta-analysis of randomized controlled trials comparing drug-eluting stents with bare-metal stents in saphenous vein graft interventions. Catheter Cardiovasc Interv, 2018.
  61. Shah, R. Long-Term Survival With On-Pump Coronary Artery Bypass Grafting. J Am Coll Cardiol, 72 (3), 344, 2018.
  62. Shah, R. Optimal Guideline-Directed Medical Therapy for Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol, 71 (24), 2861-2862, 2018.
  63. Brilakis, ES, Edson, R, Bhatt, DL, Goldman, S, Holmes, DR, Rao, SV, Shunk, K, Rangan, BV, Mavromatis, K, Ramanathan, K, Bavry, AA, Garcia, S, Latif, F, Armstrong, E, Jneid, H, Conner, TA, Wagner, T, Karacsonyi, J, Uyeda, L, Ventura, B, Alsleben, A, Lu, Y, Shih, MC, Banerjee, S, ,. Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial. Lancet, 391 (10134), 1997-2007, 2018.
  64. Shah, R, Latham, SB, Khan, SA, Shahreyar, M, Hwang, I, Jovin, IS. A comprehensive meta-analysis of stem cell therapy for chronic angina. Clin Cardiol, 41 (4), 525-531, 2018.
  65. Shah, R. Bioresorbable polymer drug-eluting stents. Lancet, 391 (10124), 935-936, 2018.
  66. Shah, R, Nayyar, M, Jovin, IS, Rashid, A, Bondy, BR, Fan, TM, Flaherty, MP, Rao, SV. Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke: A Systematic Review and Meta-analysis. Ann Intern Med, 168 (5), 335-342, 2018.
  67. Shah, R. Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy. Ann Intern Med, 168 (3), 233-234, 2018.
  68. Shah, R. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction. N Engl J Med, 378 (3), 299, 2018.
  69. Shah, R, Askari, R, Haji, SA, Rashid, A. Mortality and operator experience with vascular access for percutaneous coronary intervention in patients with acute coronary syndromes: A pairwise and network meta-analysis of randomized controlled trials. Int J Cardiol, 248, 114-119, 2017.
  70. Shah, R, Wood, SJ, Khan, SA, Chaudhry, A, Rehan Khan, M, Morsy, MS. High-volume forced diuresis with matched hydration using the RenalGuard System to prevent contrast-induced nephropathy: A meta-analysis of randomized trials. Clin Cardiol, 40 (12), 1242-1246, 2017.
  71. Shah, R, Sabghi, R, Dennis, M. Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy. JAMA Cardiol, 2017.
  72. Shah, R, Morsy, MS, Weiman, DS, Vetrovec, GW. Meta-Analysis Comparing Coronary Artery Bypass Grafting to Drug-Eluting Stents and to Medical Therapy Alone for Left Main Coronary Artery Disease. Am J Cardiol, 120 (1), 63-68, 2017.
  73. Shah, R, Rashid, A, Hwang, I, Fan, TM, Khouzam, RN, Reed, GL. Meta-Analysis of the Relative Efficacy and Safety of Oral P2Y12 Inhibitors in Patients With Acute Coronary Syndrome. Am J Cardiol, 119 (11), 1723-1728, 2017.
  74. Shah, R, Delgado, G, Finks, SW. Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention. Cardiovasc Diagn Ther, 7 (Suppl 2), S66-S68, 2017.
  75. Shah, R. Letter by Shah Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration". Circulation, 135 (22), e1101-e1102, 2017.
  76. Shah, R. Bioresorbable vascular scaffolds and late lumen loss. Lancet, 389 (10081), 1796-1797, 2017.
  77. Shah, R, Mattox, A, Khan, MR, Berzingi, C, Rashid, A. Contrast use in relation to the arterial access site for percutaneous coronary intervention: A comprehensive meta-analysis of randomized trials. World J Cardiol, 9 (4), 378-383, 2017.
  78. Shah, R. Optical coherence tomography-guided PCI. Lancet, 389 (10079), 1607, 2017.
  79. Habibi, SE, Shah, R, Berzingi, CO, Melchior, R, Sumption, KF, Jovin, IS. Left main coronary artery stenosis: severity evaluation and implications for management. Expert Rev Cardiovasc Ther, 15 (3), 157-163, 2017.
  80. Shah, R. Routine Ischemic Work-Up for Patients With New-Onset Heart Failure. J Am Coll Cardiol, 69 (3), 363-364, 2017.
  81. Shah, R. Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents. Ann Intern Med, 165 (11), 828-829, 2016.
  82. Shah, R, Rashid, A. Stroke risk from manual aspiration thrombectomy during primary percutaneous coronary intervention: An updated comprehensive meta-analysis of randomized controlled trials. Int J Cardiol, 222, 636-8, 2016.
  83. Shah, R, Berzingi, C, Mumtaz, M, Jasper, JB, Goswami, R, Morsy, MS, Ramanathan, KB, Rao, SV. Meta-Analysis Comparing Complete Revascularization Versus Infarct-Related Only Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. Am J Cardiol, 118 (10), 1466-1472, 2016.
  84. Shah, R, Matin, K, Rogers, KC, Rao, SV. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv, 2016.
  85. Shah, R, Rao, SV. Reply: The Hidden Players. JACC Cardiovasc Interv, 9 (18), 1973, 2016.
  86. Shah, R, Ahmed, AJ. Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome. JACC Cardiovasc Interv, 9 (14), 1517-8, 2016.
  87. Shah, R. Optimum technique to reduce risk of stent thrombosis. Lancet, 388 (10040), 127, 2016.
  88. Shah, R, Rogers, KC, Ahmed, AJ, King, BJ, Rao, SV. Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv, 9 (13), 1313-20, 2016.
  89. Shah, R, Ramos-Bondy, B, Mizeracki, A. Risk of stent thrombosis with bioresorbable vascular scaffolds. Lancet, 387 (10031), 1903, 2016.
  90. Shah, R, Rashid, A, Mizeracki, A. An Elderly Unresponsive Patient. JAMA, 315 (17), 1896-7, 2016.
  91. Shah, R, Khan, MR, Holt, LC. An Elderly Patient With Palpitation and a Negative Nuclear Stress Test Result. JAMA Intern Med, 176 (4), 542-4, 2016.
  92. Shah, R, Qualls, Z. Diaphragmatic stimulation caused by cardiac resynchronization treatment. CMAJ, 2016.
  93. Shah, R, John, E, Fan, TH, Ruff, G, Rehan Khan, M, Holt, LC. A Patient with Metastatic Small-Cell Lung Cancer and Giant Right Ventricular Mass. Echocardiography, 33 (3), 491-3, 2016.
  94. Shah, R, Rogers, KC, Matin, K, Askari, R, Rao, SV. An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention. Am Heart J, 171 (1), 14-24, 2016.
  95. Shah, R. Bivalirudin in Acute Coronary Syndromes. N Engl J Med, 374 (3), 285, 2016.
  96. Shah R. Invasive strategy in acute coronary syndrome. Lancet, 387 (387), 2503, 2016.
  97. Rao SV, Shah R. The Fuzzy Math of Anticoagulation and Access Site: When 1 + 1 Does Not Always Equal 2 (Editorial).. JACC Cardiovascular interventions., 2016.
  98. Shah, R, Gardner, JD. Radial versus femoral access for cardiac catheterisation. Lancet, 386 (10011), 2392-3, 2015.
  99. Shah, R, Berzingi, C, Fan, TH, Askari, R, Khan, MR. Cocaine-Induced Acute Aortic Dissection. J Emerg Med, 49 (3), e87-9, 2015.
  100. Shah, R. Bivalirudin versus heparin use for patients undergoing PPCI. Lancet, 385 (9982), 2045, 2015.
  101. Shah, R. β blockers in patients with heart failure and atrial fibrillation. Lancet, 385 (9978), 1618, 2015.
  102. Shah, R, Khan, MR, Fan, TH, Ruff, G, Ramanathan, KB. An 81-year-old man with an abnormal right-sided heart shadow on chest radiograph. Chest, 147 (2), e52-5, 2015.
  103. Shah, R. Fractional flow reserve-guided PCI. N Engl J Med, 372 (1), 94-5, 2015.
  104. Shah, R, Slomka, T, Rogers, KC. Dual antiplatelet treatment after stenting. Lancet, 385 (9965), 326, 2015.
  105. Shah, R, Deam, AG. Wide complex tachycardia in a patient with a family history of sudden death. JAMA Intern Med, 175 (1), 128-31, 2015.